554 related articles for article (PubMed ID: 15551293)
21. [Cerebral sinovenous thrombosis and acquired antithrombin, protein C and S deficiency during chemotherapy in a young man: report of a case].
Munoz VT; Triffet A; Cauchie P; Brohée D
Rev Med Brux; 2008; 29(6):535-9. PubMed ID: 19202708
[TBL] [Abstract][Full Text] [Related]
22. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
Hourani R; Abboud M; Hourani M; Khalifeh H; Muwakkit S
Neuropediatrics; 2008 Feb; 39(1):46-50. PubMed ID: 18504683
[TBL] [Abstract][Full Text] [Related]
23. Thrombosis in children receiving L-asparaginase. Determining patients at risk.
Shapiro AD; Clarke SL; Christian JM; Odom LF; Hathaway WE
Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):400-5. PubMed ID: 8214362
[TBL] [Abstract][Full Text] [Related]
24. Characterization of hypertriglyceridemia induced by L-asparaginase therapy for acute lymphoblastic leukemia and malignant lymphoma.
Tozuka M; Yamauchi K; Hidaka H; Nakabayashi T; Okumura N; Katsuyama T
Ann Clin Lab Sci; 1997; 27(5):351-7. PubMed ID: 9303174
[TBL] [Abstract][Full Text] [Related]
25. [Coagulation disorders during treatment with l-asparaginase preparations].
Dobaczewski G
Wiad Lek; 1998; 51 Suppl 4():227-32. PubMed ID: 10731973
[TBL] [Abstract][Full Text] [Related]
26. [Cerebral thrombosis in a child with acute lymphocytic leukemia during L-asparaginase therapy].
Horigome Y; Hanada T; Inudoh M; Takita H
Rinsho Ketsueki; 1989 Aug; 30(8):1284-8. PubMed ID: 2601047
[TBL] [Abstract][Full Text] [Related]
27. Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience.
Couturier MA; Huguet F; Chevallier P; Suarez F; Thomas X; Escoffre-Barbe M; Cacheux V; Pignon JM; Bonmati C; Sanhes L; Bories P; Daguindau E; Dorvaux V; Reman O; Frayfer J; Orvain C; Lhéritier V; Ifrah N; Dombret H; Hunault-Berger M; Tanguy-Schmidt A
Am J Hematol; 2015 Nov; 90(11):986-91. PubMed ID: 26214580
[TBL] [Abstract][Full Text] [Related]
28. Antithrombin deficiency after prolonged asparaginase treatment in children with acute lymphoblastic leukemia.
Ranta S; Heyman MM; Jahnukainen K; Taskinen M; Saarinen-Pihkala UM; Frisk T; Söderhäll S; Petrini P; Mäkipernaa AM
Blood Coagul Fibrinolysis; 2013 Oct; 24(7):749-56. PubMed ID: 24056293
[TBL] [Abstract][Full Text] [Related]
29. Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia.
Zalewska-Szewczyk B; Andrzejewski W; Bodalski J
Pediatr Blood Cancer; 2004 Oct; 43(5):600-2. PubMed ID: 15382279
[TBL] [Abstract][Full Text] [Related]
30. Management of L-asparaginase induced prothrombotic state in acute lymphoblastic leukemia.
Parma M; Belotti D; Pogliani EM
Haematologica; 1996; 81(2):191. PubMed ID: 8641657
[No Abstract] [Full Text] [Related]
31. Coagulopathic side effect of L-asparaginase on fibrinogen level in childhood acute lymphoblastic leukemia during induction phase.
Alqasim AMZ; Al-Hadithi RH; Al-Khalidi AN
Hematol Oncol Stem Cell Ther; 2019 Mar; 12(1):67-69. PubMed ID: 29406239
[TBL] [Abstract][Full Text] [Related]
32. Transient hyperammonemia due to L-asparaginase therapy in children with acute lymphoblastic leukemia or non-Hodgkin lymphoma.
Jörck C; Kiess W; Weigel JF; Mütze U; Bierbach U; Beblo S
Pediatr Hematol Oncol; 2011 Feb; 28(1):3-9. PubMed ID: 20615069
[TBL] [Abstract][Full Text] [Related]
33. Allogeneic bone marrow transplantation after L-asparaginase-induced pancreatitis in a patient with acute lymphoblastic leukemia.
Yamada Y; Ito K; Watanabe Y; Nosaka K; Horikawa K; Hidaka M; Kawano F; Sasaki Y; Mitsuya H; Asou N
Leuk Res; 2008 Dec; 32(12):1944-6. PubMed ID: 18502503
[No Abstract] [Full Text] [Related]
34. Negligible hemostatic toxicity of intermediate-dose Erwinase in adult patients with acute lymphoblastic leukemia: preliminary data.
Nocentini F; Gugliotta L; Catani L; Vianelli N; Baravelli S; Martelli V; Tura S
Haematologica; 1994; 79(6):546-9. PubMed ID: 7896215
[TBL] [Abstract][Full Text] [Related]
35. Greater decrease of fibrinogen as compared to antithrombin III in L-asparaginase treated leukemia patients.
Vicarioto M; Rosolen A; Cappellato MG; Zanesco L; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):663-9. PubMed ID: 2435632
[TBL] [Abstract][Full Text] [Related]
36. [Venous thrombosis of cranial sinuses in asparaginase therapy. A case report].
Schulz U; Mann G; Zoubek A; Gadner H
Klin Padiatr; 1994; 206(4):342-5. PubMed ID: 7967436
[TBL] [Abstract][Full Text] [Related]
37. Antithrombin supplementation III in childhood acute lymphoblastic leukemia treated with L-asparaginase.
Matsuzaki A; Suminoe A; Hara T
Pediatr Hematol Oncol; 2002 Dec; 19(8):601-3. PubMed ID: 12487838
[TBL] [Abstract][Full Text] [Related]
38. Cerebrovascular complications of L-asparaginase in the therapy of acute lymphoblastic leukemia.
Kieslich M; Porto L; Lanfermann H; Jacobi G; Schwabe D; Böhles H
J Pediatr Hematol Oncol; 2003 Jun; 25(6):484-7. PubMed ID: 12794528
[TBL] [Abstract][Full Text] [Related]
39. Octreotide therapy in asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia.
Wu SF; Chen AC; Peng CT; Wu KH
Pediatr Blood Cancer; 2008 Dec; 51(6):824-5. PubMed ID: 18726919
[TBL] [Abstract][Full Text] [Related]
40. L-asparaginase in acute lymphoblastic leukemia treatment: the role of human antithrombin III concentrates in regulating the prothrombotic state induced by therapy.
Pogliani EM; Parma M; Baragetti I; Mostarda G; Rivolta F; Maffé P; Corneo G
Acta Haematol; 1995; 93(1):5-8. PubMed ID: 7725851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
